Apigenin potentiates the growth inhibitory effects by IKK-β-mediated NF-κB activation in pancreatic cancer cells

Toxicology Letters

Volumn 224, Issue 1, 2014, Pages 157-164

  Wu, Ding Guo ^a   Yu, Peng ^a   Li, Jian Wei ^a   Jiang, Peng ^a   Sun, Jing ^a   Wang, Huai Zhi ^a   Zhang, Lei Da ^a   Wen, Ming Bo ^b   Bie, Ping ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b People's Liberation Army 181 Hospital   (China)

Author keywords

Apigenin; IKK ; NF B; Pancreatic cancer

Indexed keywords

APIGENIN; BETA ACTIN; CASPASE 3; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P50; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BINDING AFFINITY; CANCER CELL; CANCER INHIBITION; CELL DEATH; CELL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; ENZYME ACTIVITY; FEMALE; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION;

APIGENIN; IKK-Β; NF-ΚB; PANCREATIC CANCER;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; APIGENIN; CELL LINE, TUMOR; CELL PROLIFERATION; DNA; FEMALE; HUMANS; I-KAPPA B KINASE; MICE; MICE, INBRED BALB C; NF-KAPPA B; PANCREATIC NEOPLASMS;

EID: 84888058645     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2013.10.007     Document Type: Article

References (42)

1. Angst E., Park J.L., Moro A., Lu Q.Y., Lu X., Li G., King J., Chen M., Reber H.A., Go V.L., Eibl G., Hines O.J. The flavonoid quercetin inhibits pancreatic cancer growth in vitro and in vivo. Pancreas 2012, 42:223-229.
2. Arango D., Morohashi K., Yilmaz A., Kuramochi K., Parihar A., Brahimaj B., Grotewold E., Doseff A.I. Molecular basis for the action of a dietary flavonoid revealed by the comprehensive identification of apigenin human targets. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:E2153-E2162.
3. Baeuerle P.A., Baltimore D. NF-κB: ten years after. Cell 1996, 87:13-20.
4. Bernier M., Kwon Y.K., Pandey S.K., Zhu T.N., Zhao R.J., Maciuk A., He H.J., Decabo R., Kole S. Binding of manumycin A inhibits IκB kinase beta activity. J. Biol. Chem. 2006, 281:2551-2561.
5. Brandi G., Pantaleo M.A., Biasco G., Paterini P. Activated NF-κB in colorectal cancer: predictive or prognostic factor. J. Clin. Oncol. 2008, 26:1388-1389.
6. Budhraja A., Gao N., Zhang Z., Son Y.O., Cheng S., Wang X., Ding S., Hitron A., Chen G., Luo J., Shi X. Apigenin induces apoptosis in human leukemia cells and exhibits anti-leukemic activity in vivo. Mol. Cancer Ther. 2012, 11:132-142.
7. Byun S., Park J., Lee E., Lim S., Yu J.G., Lee S.J., Chen H., Dong Z., Lee K.W., Lee H.J. Src kinase is a direct target of apigenin against UVB-induced skin inflammation. Carcinogenesis 2013, 34:397-405.
8. Cascinu S., Scartozzi M., Carbonari G., Pierantoni C., Verdecchia L., Mariani C., Squadroni M., Antognoli S., Silva R.R., Giampieri R., Berardi R. COX-2 and NF-κB overexpression is common in pancreatic cancer but does not predict for COX-2 inhibitors activity in combination with gemcitabine and oxaliplatin. Am. J. Clin. Oncol. 2007, 30:526-530.
9. Chen P.H., Yang C.R. Decoy receptor 3 expression in AsPC-1 human pancreatic adenocarcinoma cells via the phosphatidylinositol 3-kinase-, Akt-, and NF-κB-dependent pathway. J. Immunol. 2008, 181:8441-8449.
10. Das S., Das J., Samadder A., Boujedaini N., Khuda-Bukhsh A.R. Apigenin-induced apoptosis in A375 and A549 cells through selective action and dysfunction of mitochondria. Exp. Biol. Med. (Maywood) 2012, 237:1433-1448.
11. deGraffenried L.A., Chandrasekar B., Friedrichs W.E., Donzis E., Silva J., Hidalgo M., Freeman J.W., Weiss G.R. NF-κB inhibition markedly enhances sensitivity of resistant breast cancer tumor cells to tamoxifen. Ann. Oncol. 2004, 15:885-890.
12. Franzen C.A., Amargo E., Todorovic V., Desai B.V., Huda S., Mirzoeva S., Chiu K., Grzybowski B.A., Chew T.L., Green K.J., Pelling J.C. The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism. Cancer Prev. Res. (Phila.) 2009, 2:830-841.
13. Fujioka S., Sclabas G.M., Schmidt C., Niu J., Frederick W.A., Dong Q.G., Abbruzzese J.L., Evans D.B., Baker C., Chiao P.J. Inhibition of constitutive NF-κB activity by IκB alpha M suppresses tumorigenesis. Oncogene 2003, 22:1365-1370.
14. Fulda S., Debatin K.M. Targeting apoptosis pathways in cancer therapy. Curr. Cancer Drug Targets 2004, 4:569-576.
15. Ghaneh P., Costello E., Neoptolemos J.P. Biology and management of pancreatic cancer. Gut 2007, 56:1134-1152.
16. Hsu H., Xiong J., Goeddel D.V. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell 1995, 81:495-504.
17. Karin M., Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 2000, 18:621-663.
18. Karin M., Yamamoto Y., Wang Q.M. The IKK NF-κB system: a treasure trove for drug development. Nat. Rev. Drug Discov. 2004, 3:17-26.
19. Lee S.H., Ryu J.K., Lee K.Y., Woo S.M., Park J.K., Yoo J.W., Kim Y.T., Yoon Y.B. Enhanced anti-tumor effect of combination therapy with gemcitabine and apigenin in pancreatic cancer. Cancer Lett. 2008, 259:39-49.
20. Long X., Fan M., Bigsby R.M., Nephew K.P. Apigenin inhibits antiestrogen-resistant breast cancer cell growth through estrogen receptor-alpha-dependent and estrogen receptor-alpha-independent mechanisms. Mol. Cancer Ther. 2008, 7:2096-2108.
21. Mercurio F., Zhu H., Murray B.W., Shevchenko A., Bennett B.L., Li J., Young D.B., Barbosa M., Mann M., Manning A., Rao A. IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science 1997, 278:860-866.
22. Murtaza I., Adhami V.M., Hafeez B.B., Saleem M., Mukhtar H. Fisetin, a natural flavonoid, targets chemoresistant human pancreatic cancer AsPC-1 cells through DR3-mediated inhibition of NF-κB. Int. J. Cancer 2009, 125:2465-2473.
23. Nicholas C., Batra S., Vargo M.A., Voss O.H., Gavrilin M.A., Wewers M.D., Guttridge D.C., Grotewold E., Doseff A.I. Apigenin blocks lipopolysaccharide-induced lethality in vivo and proinflammatory cytokines expression by inactivating NF-κB through the suppression of p65 phosphorylation. J. Immunol. 2007, 179:7121-7127.
24. Parrondo R., de las Pozas A., Reiner T., Rai P., Perez-Stable C. NF-κB activation enhances cell death by antimitotic drugs in human prostate cancer cells. Mol. Cancer 2010, 9:182.
25. Pham L.V., Tamayo A.T., Yoshimura L.C., Lo P., Ford R.J. Inhibition of constitutive NF-κB activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis. J. Immunol. 2003, 171:88-95.
26. Richmond A. Nf-κB, chemokine gene transcription and tumour growth. Nat. Rev. Immunol. 2002, 2:664-674.
27. Ruiz P.A., Haller D. Functional diversity of flavonoids in the inhibition of the proinflammatory NF-κB, IRF, and Akt signaling pathways in murine intestinal epithelial cells. J. Nutr. 2006, 136:664-671.
28. Shukla S., Gupta S. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor NF-κB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-κB-responsive genes. Clin. Cancer Res. 2004, 10:3169-3178.
29. Shukla S., Gupta S. Molecular targets for apigenin-induced cell cycle arrest and apoptosis in prostate cancer cell xenograft. Mol. Cancer Ther. 2006, 5:843-852.
30. Shukla S., MacLennan G.T., Flask C.A., Fu P., Mishra A., Resnick M.I., Gupta S. Blockade of beta-catenin signaling by plant flavonoid apigenin suppresses prostate carcinogenesis in TRAMP mice. Cancer Res. 2007, 67:6925-6935.
31. Shukla S., Mishra A., Fu P., MacLennan G.T., Resnick M.I., Gupta S. Up-regulation of insulin-like growth factor binding protein-3 by apigenin leads to growth inhibition and apoptosis of 22Rv1 xenograft in athymic nude mice. FASEB J. 2005, 19:2042-2044.
32. Stehlik C., de Martin R., Binder B.R., Lipp J. Cytokine induced expression of porcine inhibitor of apoptosis protein (iap) family member is regulated by NF-κB. Biochem. Biophys. Res. Commun. 1998, 243:827-832.
33. Tabruyn S.P., Griffioen A.W. NF-κB: a new player in angiostatic therapy. Angiogenesis 2008, 11:101-106.
34. Tojima Y., Fujimoto A., Delhase M., Chen Y., Hatakeyama S., Nakayama K., Kaneko Y., Nimura Y., Motoyama N., Ikeda K., Karin M., Nakanishi M. NAK is an IκB kinase-activating kinase. Nature 2000, 404:778-782.
35. Tsai J., Zhang R., Qiu W., Su Q., Naples M., Adeli K. Inflammatory NF-κB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production. Am. J. Physiol. Gastrointest. Liver Physiol. 2009, 296:G1287-G1298.
36. Ujiki M.B., Ding X.Z., Salabat M.R., Bentrem D.J., Golkar L., Milam B., Talamonti M.S., Bell R.H., Iwamura T., Adrian T.E. Apigenin inhibits pancreatic cancer cell proliferation through G2/M cell cycle arrest. Mol. Cancer 2006, 5:76.
37. Wang C.Y., Mayo M.W., Baldwin A.S. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 1996, 274:784-787.
38. Wen D., Nong Y., Morgan J.G., Gangurde P., Bielecki A., Dasilva J., Keaveney M., Cheng H., Fraser C., Schopf L., Hepperle M., Harriman G., Jaffee B.D., Ocain T.D., Xu Y. A selective small molecule IκB Kinase beta inhibitor blocks nuclear factor κB-mediated inflammatory responses in human fibroblast-like synoviocytes, chondrocytes, and mast cells. J. Pharmacol. Exp. Ther. 2006, 317:989-1001.
39. Woronicz J.D., Gao X., Cao Z., Rothe M., Goeddel D.V. IκB kinase-beta: NF-κB activation and complex formation with IκB kinase-alpha and NIK. Science 1997, 278:866-869.
40. Yin M.J., Yamamoto Y., Gaynor R.B. The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-beta. Nature 1998, 396:77-80.
41. Yip-Schneider M.T., Nakshatri H., Sweeney C.J., Marshall M.S., Wiebke E.A., Schmidt C.M. Parthenolide and sulindac cooperate to mediate growth suppression and inhibit the nuclear factor-κB pathway in pancreatic carcinoma cells. Mol. Cancer Ther. 2005, 4:587-594.
42. Zerbini L.F., Wang Y., Czibere A., Correa R.G., Cho J.Y., Ijiri K., Wei W., Joseph M., Gu X., Grall F., Goldring M.B., Zhou J.R., Libermann T.A. NF-κB-mediated repression of growth arrest- and DNA-damage-inducible proteins 45alpha and gamma is essential for cancer cell survival. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:13618-13623.